37 results on '"Vigliotti, Maria Luigia"'
Search Results
2. Rituximab Therapy for Chronic Lymphocytic Leukemia-Associated Autoimmune Hemolytic Anemia
3. Management of advanced bilio-pancreatic cancer. A monoinstitutional observation
4. Diagnosis of liver nodules observed in chronic liver disease patients during ultrasound screening for early detection of hepatocellular carcinoma
5. Adverse drug reactions after intravenous rituximab infusion are more common in hematologic malignancies than in autoimmune disorders and can be predicted by the combination of few clinical and laboratory parameters: results from a retrospective, multicenter study of 374 patients
6. Adverse drug reactions after intravenous rituximab infusion are more common in hematologic malignancies than in autoimmune disorders and can be predicted by the combination of few clinical and laboratory parameters: results from a retrospective, multicenter study of 374 patients.
7. Complementary and alternative medicine use in patients with chronic lymphocytic leukemia: an Italian multicentric survey
8. Bortezomib as salvage treatment for heavily pretreated relapsed lymphoma patients: a multicenter retrospective study
9. A randomized trial with melphalan and prednisone versus melphalan and prednisone plus thalidomide in newly diagnosed multiple myeloma patients not eligible for autologous stem cell transplant
10. Rituximab to treat chronic lymphoproliferative disorder‐associated pure red cell aplasia
11. Rapid Transformation to Aggressive B-Cell Lymphoma, in a Case of Mixed Cellularity Hodgkin Lymphoma Subtype : A Rare Event
12. Long Term Disease Free Survival in Patient with Linfoplasmocytic Lymphoma and Regression of Associated Severe Renal Failure after Treatment with Bortezomib.
13. Non-Hodgkin Lymphoma Involving the Bone (NHLB): Report of Ten Cases.
14. Rituximab therapy for chronic lymphocytic leukemia-associated autoimmune hemolytic anemia
15. Vinorelbine, gemcitabine, procarbazine and prednisone (ViGePP) as salvage therapy in relapsed or refractory aggressive non-Hodgkin's lymphoma (NHL): Results of a phase II study conducted by theGruppo Italiano per lo Studio dei Linfomi
16. Intensity of 18Fluorodeoxyglucose Uptake in Positron Emission Tomography Is Associated with Unfavorable Prognostic Factors in Untreated Follicular Lymphoma.
17. Primary breast lymphoma: outcome of 7 patients and a review of the literature
18. Prevention of high-dose melphalan-induced mucositis by cryotherapy
19. High-Dose of Epoietin Alfa in Patients with Low-Risk Myelodysplastic Syndromes (MDS): A Single Institution Experience.
20. Guillain-Barré Syndrome Complicating Mobilization Therapy in a Case of B-cell Chronic Lymphocytic Leukemia
21. Linezolid-induced bradycardia: a case report
22. Primary central nervous system lymphoma (PCNSL) in immunocompetent adults: analysis of a retrospective series of patients treated using idarubicin-containing regimen and radiotherapy
23. Late and Long-lasting Response in an Adult Chronic Idiopathic Thrombocytopenic Purpura after Extended Course of Rituximab
24. Quantitative Evaluation of CD52 Expression in B-Cell Chronic Lymphocytic Leukemia
25. Primary Gastric Lymphoma for Stage I/II1 E: Operative and Conservative Management in Retrospective Data from 71 Cases
26. CD38 expression does not change in B-cell chronic lymphocytic leukemia
27. Complementary and alternative medicine use in patients with chronic lymphocytic leukemia: an Italian multicentric survey.
28. Bortezomib as salvage treatment for heavily pretreated relapsed lymphoma patients: a multicenter retrospective study.
29. Rituximab to treat chronic lymphoproliferative disorder-associated pure red cell aplasia.
30. Vinorelbine, gemcitabine, procarbazine and prednisone (ViGePP) as salvage therapy in relapsed or refractory aggressive non-Hodgkin's lymphoma (NHL): Results of a phase II study conducted by the Gruppo Italiano per lo Studio dei Linfomi.
31. ATL>Diagnosis of liver nodules observed in chronic liver disease patients during ultrasound screening for early detection of hepatocellular carcinoma.
32. Letter to Editor.
33. Letter to Editor.
34. Adverse drug reactions after intravenous rituximab infusion are more common in hematologic malignancies than in autoimmune disorders and can be predicted by the combination of few clinical and laboratory parameters: results from a retrospective, multicenter study of 374 patients
35. Complementary and alternative medicine use in patients with chronic lymphocytic leukemia: an Italian multicentric survey
36. Nonpeghylated liposomal doxorubicin combination regimen (R-COMP) for the treatment of lymphoma patients with advanced age or cardiac comorbidity.
37. Improvement of B-cell chronic lymphocytic leukemia during haemodialysis: possible role for endogenous production of factors involved in angiogenesis and apoptosis?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.